1. Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group
- Author
-
Gregucci, F., Fozza, A., Falivene, S., Smaniotto, D., Morra, A., Daidone, A., Barbara, R., Ciabattoni, A., Andrulli, D., Arcidiacono, F., Baiocchi, C., Baldissera, A., Barbarino, R., Bartoncini, S., Bono, M., Buffoli, A., Campanella, B., Campoccia, S., Catalano, G., Cavallari, M., Cerreta, V., Deantonio, L., De Rose, F., Del Bufalo, S., Digennaro, D., Doino, D., Evangelista, G., Fedele, F., Fiorentino, A., Fodor, A., Fontana, A., Fusco, V., Gatti, M., Gerardi, M., Giannini, M., Girlando, A., Guenzi, M., Guida, C., Huscher, A., Iannone, T., Iorio, V., Ippolito, E., Ivaldi, G., La Porta, M., Lazzari, G., Lioce, M., Lora, O., Macchia, G., Mangiacotti, M. G., Marafioti, L., Marino, L., Marmiroli, L., Maucieri, A., Maurizi, F., Mazzuoli, L., Meattini, I., Meduri, B., Montesi, G., Munoz, F., Nuzzo, M., Orru, S., Parisi, S., Pasinetti, N., Pedretti, S., Perrucci, E., Piva, D., Prisco, A., Ravo, V., Santacaterina, A., Scolaro, T., Serafini, F., Spigone, B., Tolento, G., Vidali, C., Vitucci, P., and Zini, G.
- Subjects
Hypofractionated Radiotherapy ,medicine.medical_specialty ,medicine.medical_treatment ,Breast Neoplasms ,Breast cancer radiotherapy ,Nationwide survey ,Hypofractionated radiotherapy ,030218 nuclear medicine & medical imaging ,AIRO ,Breast cancer ,Partial-breast irradiation ,Radiotherapy and neoadjuvant therapy ,Re-irradiation ,Survey ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Practice Patterns, Physicians' ,Medical prescription ,Societies, Medical ,Clinical Oncology ,business.industry ,General surgery ,Radiation Oncologists ,General Medicine ,medicine.disease ,Clinical Practice ,Radiation therapy ,Italy ,030220 oncology & carcinogenesis ,Female ,business - Abstract
To investigate the present attitude of the Italian Radiation Oncologists in the management of breast cancer (BC) concerning hypofractionated radiotherapy (hRT), partial-breast irradiation (PBI), re-irradiation (rRT) and radiotherapy after neoadjuvant chemotherapy (post-NAC RT). A nationwide, 21-point questionnaire was distributed online via SurveyMonkey. Seventy-four Italian Radiotherapy Centers answered to the survey. In most cases, the responding centers treated more than 100 BC patients/year between January 2016 and December 2017. Almost half of responding centers (49%) treated patients with hRT, out of these, 95% as routine practice for early-stage BC. Dose prescriptions ranged between 39 and 45 Gy indicating a high use of moderate hRT. The chest wall and regional lymph nodes were irradiated with hRT by 13% and 15% of the responding centers, respectively. PBI was used by 60% of responders, with different techniques. Only 0.6% of participants perform rRT after BC recurrence. Finally, only 11% of the interviewed centers responded to their attitude toward post-NAC RT, which, however, was indicated in 97% of patients after breast-conserving surgery. This survey shows a fairly good use of hRT and a moderate practice of PBI in Italy. Some practices like hRT to the chest wall and regional lymph nodes as well as rRT need further verification. Likewise, the management of post-NAC RT is very heterogeneous. Future national clinical collaborative studies are advocated in order to investigate these controversial topics about breast cancer radiotherapy.
- Published
- 2020